ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,735Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 807

$1.48M Total Retail Price of All Prescriptions

Rank: 1 out of 807

955 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 955 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 955 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 24,929 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 1,156 1,046 1 1
LISINOPRIL 1,064 942 2 2
LEVOTHYROXINE SODIUM 1,016 931 3 3
FUROSEMIDE 993 953 4 6
OMEPRAZOLE 911 833 5 4
METOPROLOL TARTRATE 841 769 6 8
AMLODIPINE BESYLATE 739 700 7 5
CITALOPRAM HBR 610 588 8 17
WARFARIN SODIUM 565 543 9 10
POTASSIUM CHLORIDE 544 510 10 18
HYDROCODONE-ACETAMINOPHEN 466 424 S3 11 15
SERTRALINE HCL 411 366 12 22
DONEPEZIL HCL 390 373 13 31
LACTULOSE 380 273 14 142
NAMENDA 361 349 15 54
MIRTAZAPINE 358 336 16 38
METOPROLOL SUCCINATE 358 343 16 13
GABAPENTIN 349 328 18 16
HYDROCHLOROTHIAZIDE 337 318 19 9
CARBIDOPA-LEVODOPA 328 323 20 64
LOSARTAN POTASSIUM 321 321 21 14
POLYETHYLENE GLYCOL 3350 303 265 22 40
ALENDRONATE SODIUM 302 294 23 20
ATORVASTATIN CALCIUM 300 255 24 11
TRAMADOL HCL 276 247 25 19
LANTUS SOLOSTAR 275 214 26 42
TRAZODONE HCL 275 263 26 25
DIGOXIN 273 259 28 41
ATENOLOL 271 271 29 7
QUETIAPINE FUMARATE 259 251 30 66
NOVOLOG FLEXPEN 227 171 31 75
PEN NEEDLE 213 176 32 63
CARVEDILOL 213 212 32 35
DIOVAN 210 195 34 46
METFORMIN HCL 201 172 35 12
TAMSULOSIN HCL 199 186 36 27
LANTUS 195 157 37 45
PRAVASTATIN SODIUM 193 192 38 21
CLOPIDOGREL 192 171 39 47
ALLOPURINOL 186 172 40 26
RANITIDINE HCL 185 161 41 34
CYMBALTA 175 131 42 73
ESCITALOPRAM OXALATE 160 158 43 115
ISOSORBIDE MONONITRATE ER 157 157 44 36
PREDNISONE 145 140 45 24
PLAVIX 144 133 46 60
GLIPIZIDE XL 138 138 47 94
TRIAMCINOLONE ACETONIDE 137 135 48 98
LATANOPROST 133 128 49 193
FLUTICASONE PROPIONATE 132 124 50 30
RISPERIDONE 129 121 51 85
IPRATROPIUM-ALBUTEROL 126 78 52 126
ZOLPIDEM TARTRATE 124 106 53 23
CRESTOR 122 100 54 32
SPIRIVA 118 109 55 50
SEROQUEL 117 116 56 155
FAMOTIDINE 116 84 57 90
NOVOLOG 114 83 58 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 97 59 28
ZETIA 108 97 60 59
HYDRALAZINE HCL 106 106 61 62
VENLAFAXINE HCL ER 106 91 61 91
VOLTAREN 100 99 63 263
LEVETIRACETAM 100 58 63 119
ADVAIR DISKUS 96 93 65 33
GLIPIZIDE 95 82 66 58
INSULIN SYRINGE 95 71 66 102
FENTANYL 92 79 S2 68 65
AGGRENOX 91 91 69 161
TRIAMTERENE-HCTZ 90 90 70 29
BUPROPION XL 89 54 71 147
SPIRONOLACTONE 88 88 72 48
PROPRANOLOL HCL 84 50 73 101
CIPROFLOXACIN HCL 83 78 74 72
PHENYTOIN SODIUM EXTENDED 83 57 74 172
PANTOPRAZOLE SODIUM 80 80 76 44
NEXIUM 80 68 76 68
DILTIAZEM 24HR ER 79 77 78 189
FENOFIBRATE 75 60 79 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 68 80 134
ABILIFY 71 31 81 288
BACLOFEN 71 30 81 123
EVISTA 70 70 83 128
ALBUTEROL SULFATE 70 59 83 139
PAROXETINE HCL 69 66 85 49
PREMARIN 68 64 R 86 159
NYSTOP 68 34 86 125
TIMOLOL MALEATE 67 62 88 293
KLOR-CON M20 67 62 88 83
OXYBUTYNIN CHLORIDE 64 51 90 108
FLUOXETINE HCL 63 62 91 52
LAMOTRIGINE 63 22 91 298
JANUVIA 62 51 93 79
FINASTERIDE 62 62 93 89
CYCLOBENZAPRINE HCL 62 44 R 93 88
AMIODARONE HCL 61 61 96 164
LEVEMIR FLEXPEN 61 41 96 157
NOVOLIN 70-30 61 45 96 302
PRAMIPEXOLE DIHYDROCHLORIDE 59 59 99 121
NITROSTAT 58 57 100 104
GLIPIZIDE ER 58 47 100 67
CLOTRIMAZOLE-BETAMETHASONE 56 56 102 198
DIVALPROEX SODIUM 55 42 103 114
OLANZAPINE 55 39 103 119
PROAIR HFA 55 44 103 43
BUSPIRONE HCL 54 54 106 160
ENALAPRIL MALEATE 53 53 107 110
LOVASTATIN 52 48 108 39
AZITHROMYCIN 50 48 109 57
NIFEDIPINE ER 50 46 109 163
GLYBURIDE 50 50 R 109 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.